Home|Journals|Articles by Year

Directory for Medical Articles

Open Access

Original Research

Anticonvulsant action of aqueous extract of Centella asiatica and sodium valproate—A comparative study in pentylenetetrazole-induced seizures

Megaravalli R Manasa, Idoor D Sachin.

Background: Antiepileptics available currently cause teratogenicity and chronic toxicity. Several plant extracts exhibit the potential to be developed into newer antiepileptics.

Aims and Objective: To evaluate the anticonvulsant action of aqueous extract of Centella asiatica and compare it with sodium valproate in pentylenetetrazole (PTZ)-induced seizures in albino mice.

Materials and Methods: Twenty-four male albino mice weighing 18–30 g were divided into four groups. Group I was administered distilled water, group II sodium valproate (300 mg/kg i.p.), and groups III and IV aqueous extract of C. asiatica (100 mg/kg and 300 mg/kg), respectively. Seizures were induced by giving PTZ (80 mg/kg s.c.) 1 h after administration of the respective treatments. Suppression of clonic seizure was considered as an indicator of anticonvulsant action of the compound.

Result: The aqueous extract of C. asiatica at both doses (100 mg/kg and 300 mg/kg) suppressed the clonic seizures in mice, and this was statistically significant. The anticonvulsant action of the extract at a dose of 300 mg/kg was comparable to that of sodium valproate in this study.

Conclusion: The aqueous extract of C. asiatica at a dose of 300 mg/kg has shown anticonvulsant action comparable to sodium valproate in PTZ-induced seizures.

Key words: Centella asiatica; Pentylenetetrazole, Sodium Valproate

Similar Articles

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Journal Finder
Covid-19 Trends and Statistics
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.